Expression of protease-activated receptors and tissue factor in human liver

被引:0
|
作者
Anne Rullier
Nathalie Senant
Walter Kisiel
Paulette Bioulac-Sage
Charles Balabaud
Brigitte Le Bail
Jean Rosenbaum
机构
[1] Université Victor Segalen Bordeaux 2,GREF/INSERM E362
[2] Université Victor Segalen Bordeaux 2,Department of Pathology,
[3] IFR 66,Department of Pathology
[4] CHU de Bordeaux,undefined
[5] Hôpital Pellegrin,undefined
[6] University of New Mexico School of Medicine,undefined
来源
Virchows Archiv | 2006年 / 448卷
关键词
Thrombin receptor; Tissue factor; Human liver; Immunohistochemistry; Liver neoplasm;
D O I
暂无
中图分类号
学科分类号
摘要
Thrombin, acting via protease-activated receptors (PARs), and tissue factor (TF) are involved in inflammation, tissue repair and tumorigenesis. Hepatocellular carcinomas (HCCs) usually complicate chronic liver diseases characterised by inflammation and fibrosis. The aim of this study was to describe the expression of PARs and TF in normal liver, cirrhosis and HCCs. We performed an immunohistochemical detection of PAR-1, PAR-3, PAR-4 and human TF in human tissue samples from 19 subnormal livers, 33 cirrhosis and 30 HCCs. PAR-1 was found on endothelial cells of sinusoids and larger vessels. In cirrhosis, spindle-shaped cells within septa and T lymphocytes were PAR-1 positive. A few PAR-1-positive tumour cells were found in 10% of HCCs. PAR-4 expression was restricted to macrophages, B lymphocytes and nerves. PAR-3 expression was rare. Unexpectedly, TF was expressed in 95% of normal livers and in 94% of cirrhosis but only in 50% of HCCs (p<0.001). Staining was mostly hepatocellular. No association existed between TF labelling and clinicopathological characteristics of HCCs. In conclusion, the pattern of expression of PARs is compatible with its role in chronic liver disease by promoting inflammation via immune cells and neurogenic stimulation. However, our data do not support a role for PARs or TF in HCC progression.
引用
收藏
页码:46 / 51
页数:5
相关论文
共 50 条
  • [41] Thrombin signalling and protease-activated receptors
    Coughlin, SR
    NATURE, 2000, 407 (6801) : 258 - 264
  • [42] Protease-activated receptors in the musculoskeletal system
    Mackie, E. J.
    Loh, L. -H.
    Sivagurunathan, S.
    Uaesoontrachoon, K.
    Yoo, H. J.
    Wong, D.
    Georgy, S. R.
    Pagel, C. N.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7): : 1169 - 1184
  • [43] The cardiovascular actions of protease-activated receptors
    Steinberg, SF
    MOLECULAR PHARMACOLOGY, 2005, 67 (01) : 2 - 11
  • [44] Proteases, Protease-Activated Receptors, and Atherosclerosis
    Ruf, Wolfram
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (06) : 1252 - 1254
  • [45] Protease-activated receptors: An illustrated review
    Han, Xu
    Nieman, Marvin T.
    Kerlin, Bryce A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (01) : 17 - 26
  • [46] PROTEASE-ACTIVATED RECEPTORS START A FAMILY
    COUGHLIN, SR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9200 - 9202
  • [47] Protease-activated receptors in vascular biology
    Coughlin, SR
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (01) : 298 - 307
  • [48] Protease-activated receptors and inflammatory hyperalgesia
    Vergnolle, N
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 : 173 - 176
  • [49] Protease-activated Receptors and Myocardial Infarction
    Antoniak, Silvio
    Pawlinski, Rafal
    Mackman, Nigel
    IUBMB LIFE, 2011, 63 (06) : 383 - 389
  • [50] Protease-activated receptors and platelet function
    Coughlin, SR
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 353 - 356